ClinConnect ClinConnect Logo
Search / Trial NCT07073248

Effects of iTBS on Motor Recovery of Upper Extremity in Chronic Stroke Patients.

Launched by DANDERYD HOSPITAL · Jul 9, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Stroke I Tbs Tms Motor Cortex Chronic Stroke Patients Hand Dexterity Hemiparesis

ClinConnect Summary

This clinical trial is studying a new way to help people recover movement and function in their arms and hands after having a stroke, especially those who have lived with stroke-related weakness for more than six months. The researchers are testing a treatment called intermittent Theta Burst Stimulation (iTBS), which is a safe, non-invasive method that uses gentle brain stimulation to support rehabilitation and improve motor recovery. They also want to understand how this treatment might change brain activity and connections.

People who are eligible to join this study are adults over 18 years old who have had a stroke at least six months ago and still have some weakness in their arm or hand. However, the study is not yet open for enrolling participants. If you take part, you can expect to receive this brain stimulation as part of your therapy, and you will likely have brain scans to help the researchers observe changes. Some people won’t be able to join, such as those with metal implants, epilepsy, severe mental health conditions, pregnancy, or other health issues that make intense physical therapy difficult. This study aims to find new ways to improve arm and hand function after stroke, offering hope for better recovery in the long term.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age over 18
  • Chronic stroke (\>6 months)
  • Residual hemiparesis FM-UE\>17
  • Exclusion Criteria:
  • Metal implants
  • Epilepsy/seizures
  • Pregnancy
  • Claustrophobia (related to MRIs exams)
  • Severe cognitive impairment
  • Untreated or unstable depression/anxiety
  • Other disabilities prohibiting intensive physical training

About Danderyd Hospital

Danderyd Hospital is a leading medical institution in Sweden, renowned for its commitment to advancing healthcare through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise and state-of-the-art facilities to facilitate groundbreaking research across various medical disciplines. Danderyd Hospital collaborates with academic institutions, industry partners, and healthcare professionals to enhance patient care and contribute to the development of new therapies and treatments. With a focus on ethical standards and patient safety, Danderyd Hospital aims to improve health outcomes and drive medical advancements that benefit the wider community.

Locations

Stockholm, , Sweden

Patients applied

0 patients applied

Trial Officials

Susanne Palmcrantz, PhD, Associate Professor

Principal Investigator

Dep of Clinical Sciences, Karolinska Institutet

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported